Safety profile of baricitinib for the treatment of rheumatoid arthritis over a median of 3 years of treatment: an updated integrated safety analysis LANCET RHEUMATOLOGY Genovese, M. C., Smolen, J. S., Takeuchi, T., Burmester, G., Brinker, D., Rooney, T. P., Zhong, J., Mo Daojun, Saifan, C., Cardoso, A., Issa, M., Wu, W., Winthrop, K. L. 2020; 2 (6): E347–E357

View details for Web of Science ID 000547846500022